Focused on Investigating the Bacterial Spectrum, Urinary Incontinence and Immunological Biomarkers among Women with Urinary Tract Infection
DOI:
https://doi.org/10.46966/msjar.v6i2.263Keywords:
Uropathogenic bacteria, Interleukin -6 , Interleukin-17, Urinary tract infection, Urinary IncontinenceAbstract
Urinary tract infections occur commonly in women, and 20% of them suffer from at least one urinary tract infection in their life time. The study aimed to investigate the bacterial causative agents and the prevalence of urinary incontinence, additionally quantity the serum levels of Interleukin -6 and Interleukin-17.Out of 130 women patients with suspected urinary tract infection, only 45 of them met the criteria and give bacterial growth culture. Urine samples for the isolation and identification of bacteria , confirmation of the diagnosis done by the Vitek 2 system. Blood for serum levels measurement of Interleukin -6 and Interleukin-17 compared with serum samples taken from 45 healthy women.Escherichia coli was the most common isolated bacteria among women patients represented(37.8%).From a total of 45 urinary tract infections women patients, urinary incontinence was 8 (17.77%) , and the predominant bacteria also was Escherichia coli (37.5%). Interlukin-6 and interlukin-17 showed significant differences, among the patient group than that of healthy group . In conclusion the predominant bacteria cause urinary tract infection was Escherichia coli , and urinary incontinence as a side effect of urinary tract infection . There was highly significant differences in Interleukin-6 and Interleukin-17serum level in patients compared to the control group.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sanaa Khudhur Jameel

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















